Exploring background mutational processes to decipher cancer genetic heterogeneity
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Much remains unknown about the progression and heterogeneity of mutational processes in different cancers and their diagnostic and clinical potential. A growing body of evidence supports mutation rate dependence on the local DNA sequence context for various types of mutations. We propose several tools for the analysis of cancer context-dependent mutations, which are implemented in an online computational framework MutaGene. The framework explores DNA context-dependent mutational patterns and underlying somatic cancer mutagenesis, analyzes mutational profiles of cancer samples, identifies the combinations of underlying mutagenic processes including those related to infidelity of DNA replication and repair machinery, and various other endogenous and exogenous mutagenic factors. As a result, the combination of mutagenic processes can be identified in any query sample with subsequent comparison to mutational profiles derived from malignant and benign samples. In addition, mutagen or cancer-specific mutational background models are applied to calculate expected DNA and protein site mutability to decouple relative contributions of mutagenesis and selection in carcinogenesis, thus elucidating the site-specific driving events in cancer. MutaGene is freely available at https://www.ncbi.nlm.nih.gov/projects/mutagene/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 4×
“MutaGene constructs DNA context-dependent mutational profiles and derives signatures from major cancer whole exome and genome sequencing studies available through the International Cancer Genome Consortium (ICGC) and the Cancer Genome Atlas (TCGA) repositories.”
BackgroundInfluentialMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“There is experimental evidence (47) that any missense mutations in codons of DNA-binding arginine result in a loss of function, whereas many amino acid substitutions of another arginine can be tolerated (48).”
BackgroundIntratumor Heterogeneity: Evolution through Space and Time
Swanton, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2217 · Cited by 931
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · cited 1×
“There is experimental evidence (47) that any missense mutations in codons of DNA-binding arginine result in a loss of function, whereas many amino acid substitutions of another arginine can be tolerated (48).”
Background
Research works printed but not linked: 35
- Lawrence, 2013, Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, 499, 214, 10.1038/nature12213 · DOI · Paper page
- Andor, 2016, Pan-cancer analysis of the extent and consequences of intratumor heterogeneity, Nat. Med., 22, 105, 10.1038/nm.3984 · DOI · Paper page
- Francioli, 2015, Genome-wide patterns and properties of de novo mutations in humans, Nat. Genet., 47, 822, 10.1038/ng.3292 · DOI · Paper page
- Sharp, 2016, Low genetic quality alters key dimensions of the mutational spectrum, PLoS Biol., 14, e1002419, 10.1371/journal.pbio.1002419 · DOI
- Pfeifer, 2003, On the origin of G→T transversions in lung cancer, Mutat. Res., 526, 39, 10.1016/S0027-5107(03)00013-7 · DOI
- Boutros, 2015, Spatial genomic heterogeneity within localized, multifocal prostate cancer, Nat. Genet., 47, 736, 10.1038/ng.3315 · DOI · Paper page
- Alexandrov, 2015, A mutational signature in gastric cancer suggests therapeutic strategies, Nat. Commun., 6, 8683, 10.1038/ncomms9683 · DOI · Paper page
- Poon, 2015, Mutation signatures implicate aristolochic acid in bladder cancer development, Genome Med., 7, 38, 10.1186/s13073-015-0161-3 · DOI · Paper page
- Langie, 2015, Causes of genome instability: the effect of low dose chemical exposures in modern society, Carcinogenesis, 36, S61, 10.1093/carcin/bgv031 · DOI · Paper page
- Roberts, 2013, An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers, Nat. Genet., 45, 970, 10.1038/ng.2702 · DOI · Paper page
- Sammalkorpi, 2007, Background mutation frequency in microsatellite-unstable colorectal cancer, Cancer Res., 67, 5691, 10.1158/0008-5472.CAN-06-4314 · doi:10.1158/0008-5472.can-06-4314
- Sung, 2015, Asymmetric context-dependent mutation patterns revealed through mutation-accumulation experiments, Mol. Biol. Evol., 32, 1672, 10.1093/molbev/msv055 · DOI
- Bauer, 2015, The current state of eukaryotic DNA base damage and repair, Nucleic Acids Res., 43, 10083
- Siepel, 2004, Phylogenetic estimation of context-dependent substitution rates by maximum likelihood, Mol. Biol. Evol., 21, 468, 10.1093/molbev/msh039 · DOI · Paper page
- Pfeifer, 2009, Mutational spectra of human cancer, Hum. Genet., 125, 493, 10.1007/s00439-009-0657-2 · DOI · Paper page
- Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477 · DOI · Paper page
- Helleday, 2014, Mechanisms underlying mutational signatures in human cancers, Nat. Rev. Genet., 15, 585, 10.1038/nrg3729 · DOI · Paper page
- Rogozin, 2003, Computational analysis of mutation spectra, Brief Bioinform., 4, 210, 10.1093/bib/4.3.210 · DOI
- Hollstein, 2016, Base changes in tumour DNA have the power to reveal the causes and evolution of cancer, Oncogene, 36, 158, 10.1038/onc.2016.192 · DOI
- Ardin, 2016, MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes, BMC Bioinformatics, 17, 170, 10.1186/s12859-016-1011-z · DOI · Paper page
- Gehring, 2015, SomaticSignatures: inferring mutational signatures from single-nucleotide variants, Bioinformatics, 31, 3673, 10.1093/bioinformatics/btv408 · DOI · Paper page
- Li, 2016, Balancing protein stability and activity in cancer: a new approach for identifying driver mutations affecting CBL ubiquitin ligase activation, Cancer Res., 76, 561, 10.1158/0008-5472.CAN-14-3812 · DOI · Paper page
- Li, 2017, Annotating mutational effects on proteins and protein interactions: designing novel and revisiting existing protocols, Methods Mol. Biol., 1550, 235, 10.1007/978-1-4939-6747-6_17 · DOI
- McFarland, 2013, Impact of deleterious passenger mutations on cancer progression, Proc. Natl. Acad. Sci. U.S.A., 110, 2910, 10.1073/pnas.1213968110 · DOI · Paper page
- Carter, 2009, Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations, Cancer Res., 69, 6660, 10.1158/0008-5472.CAN-09-1133 · DOI · Paper page
- Gonzalez-Perez, 2013, Computational approaches to identify functional genetic variants in cancer genomes, Nat. Methods, 10, 723, 10.1038/nmeth.2562 · DOI · Paper page
- Forbes, 2015, COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Res., 43, D805, 10.1093/nar/gku1075 · DOI · Paper page
- Yadav, 2016, The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection, Nucleic Acids Res., 44, 2075, 10.1093/nar/gkw086 · DOI · Paper page
- Coordinators, 2014, Database resources of the National Center for Biotechnology Information, Nucleic Acids Res., 42, D7, 10.1093/nar/gkt1146 · DOI · Paper page
- Alexandrov, 2013, Deciphering signatures of mutational processes operative in human cancer, Cell Rep., 3, 246, 10.1016/j.celrep.2012.12.008 · DOI · Paper page
- Rosenthal, 2016, DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution, Genome Biol., 17, 31, 10.1186/s13059-016-0893-4 · DOI · Paper page
- Pascual-Montano, 2006, Nonsmooth nonnegative matrix factorization (nsNMF), IEEE Trans Pattern Anal. Mach. Intell., 28, 403, 10.1109/TPAMI.2006.60 · DOI · Paper page
- Rogozin, 2003, Theoretical analysis of mutation hotspots and their DNA sequence context specificity, Mutat. Res., 544, 65, 10.1016/S1383-5742(03)00032-2 · DOI · Paper page
- Zhao, 2007, Methylation-dependent transition rates are dependent on local sequence lengths and genomic regions, Mol. Biol. Evol., 24, 23, 10.1093/molbev/msl156 · DOI
- Greaves, 2015, Evolutionary determinants of cancer, Cancer Discov., 5, 806, 10.1158/2159-8290.CD-15-0439 · DOI · Paper page
Cited by
Mutational signatures and mutable motifs in cancer genomes
Rogozin, I. B., Pavlov, Y. I., Goncearenco, A., De, S., Lada, A. G., Poliakov, E., Panchenko, A. R., & Cooper, D. N. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx049 · Cited by 58
Self-citationDNA polymerase η mutational signatures are found in a variety of different types of cancer
Rogozin, I. B., Goncearenco, A., Lada, A. G., De, S., Yurchenko, V., Nudelman, G., Panchenko, A. R., Cooper, D. N., & Pavlov, Y. I. (2018) · Cell Cycle · doi:10.1080/15384101.2017.1404208 · Cited by 39
Self-citationAre Next-Generation Pathogenicity Predictors Applicable to Cancer?
Ostroverkhova, D., Sheng, Y., & Panchenko, A. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168644 · Cited by 8
Self-citation
Metadata
- Authors
- Goncearenco, A., Rager, S. L., Li, M., Sang, Q.-X., Rogozin, I. B., & Panchenko, A. R.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-04
- Volume
- 45
- Issue
- W1
- Pages
- W514-W522
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2611549356
- Cited by
- 81
- References
- 16
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.